Celosia Therapeutics
About:
A biotechnology company that uses gene therapy to treat neurodegenerative diseases.
Website: https://celosiatx.com
Description:
The Celosia Therapeutics approach is the result of advances in gene therapies and a better understanding of the molecular pathways that contribute to neurodegenerative diseases.
Total Funding Amount:
$2M
Headquarters Location:
Sydney, New South Wales, Australia
Founded Date:
2022-01-01
Contact Email:
contact(AT)celosiatx.com
Founders:
Number of Employees:
1-10
Last Funding Date:
2022-11-28
IPO Status:
Private
Industries:
© 2025 bioDAO.ai